Company Filing History:
Years Active: 2010
Title: Sheldon Broedel: Innovator in Cytokine Receptor Research
Introduction
Sheldon Broedel is a notable inventor based in Baltimore, MD, who has made significant contributions to the field of biological agents and cytokine receptors. His work focuses on the development of therapeutic agents that can address inflammatory conditions, showcasing his innovative approach to medical science.
Latest Patents
Sheldon Broedel holds a patent for a biological agent that causes IL-6 receptor release. This patent describes inventions related to the use of biological agents that facilitate the release of cytokine receptors from the surface of cells. One key aspect of this invention is the unexpected finding that extending the length of an exemplary agent at the N-terminus enhances expression and production of the product by at least 10-fold. The extended protein can be utilized to prepare pharmaceutical compositions aimed at treating inflammatory conditions such as rheumatoid arthritis. Additionally, the patent identifies biological agents that cause the release of cytokine receptors not previously recognized as natural enzyme targets, including the IL-1 Type I receptor, IL-1 Type II receptor, and the IL-6 receptor. This disclosure provides valuable products, assays, expression systems, purification methods, and production protocols for developing cytokine receptor releasing proteins as therapeutic agents.
Career Highlights
Sheldon Broedel is associated with Meyer Pharmaceuticals LLC, where he continues to advance his research and innovations. His work has the potential to significantly impact the treatment of various inflammatory diseases, demonstrating his commitment to improving patient outcomes through scientific discovery.
Collaborations
Sheldon has collaborated with notable colleagues such as Tetsuya Gatanaga and Ronald L Niece, contributing to a rich environment of innovation and research.
Conclusion
Sheldon Broedel's contributions to the field of cytokine receptor research exemplify the importance of innovation in addressing complex medical challenges. His patent and ongoing work at Meyer Pharmaceuticals LLC highlight his role as a key figure in the development of therapeutic agents for inflammatory conditions.